[Clinical trial of a new corticosteroid in some aspecific inflammatory ocular diseases: dexamethasone 21-(pyridine-4-carboxylate)].
D002264:Carboxylic Acids / Q000627:therapeutic use; D002386:Cataract / Q000188:drug therapy; D003231:Conjunctivitis / Q000188:drug therapy; D003907:Dexamethasone / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy*; D005141:Eyelid Diseases / Q000188:drug therapy; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D011725:Pyridines / Q000627:therapeutic use
D002264:Carboxylic Acids; D011725:Pyridines; D003907:Dexamethasone
Sperimentazione clinica di un nuovo corticosteroide in alcune affezioni flogistiche aspecifiche oculari: desametasone 21-(4-piridincarbossilato) collirio e pomata.